gave | 08 May 2021 Saturday – 17:23 | Last Updated: 08 05 2021 – 17:23
The University of Oxford announced that they have received research ethics approval for a human clinical trial involving people who have previously had coronavirus. Accordingly, people who have had coronavirus will be exposed to the virus for the second time and the responses of the body’s immune system will be measured.
Oxford University announced that people who have had coronavirus have received ethical approval for a human clinical trial to measure the response of their immune system if they catch the virus for the second time. “The purpose of this study is to determine what type of immune response prevents reinfection,” said Professor Helen McShane. People who will participate in the clinical trial are expected to be determined next week.
With this clinical trial, the Oxford team will measure the levels of various components of the participants’ immune response, including T cells and antibodies, and then track whether participants are re-infected when exposed to the virus.
Participants must be healthy, at low risk, between the ages of 18 and 30, and have had coronavirus at least three months before participating in the trial. It was also stated that these people should have had antibodies against coronavirus, as well as having a positive Covid PCR test.